Clinical trial
Bilastine and Montelukast in Patients With Seasonal Allergic Rhinoconjunctivitis and Asthma: Efficacy of Concomitant Administration - the SKY Study
NCT02761252 is registered in ClinicalTrials.gov with Menarini International Operations Luxembourg SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bilastine and Montelukast in Patients With Seasonal Allergic Rhinoconjunctivitis and Asthma: Efficacy of Concomitant Administration - the SKY Study
- Lead sponsor
- Menarini International Operations Luxembourg SA
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 13, 2016
- Completion date
- November 24, 2016
- Enrollment
- 454 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
asthma, seasonal allergic rhinoconjunctivitis